![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 47, 49045-49054, November 19, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







¶
From the
Abramson Family Cancer Research Institute, Department of Cancer Biology and Signal Transduction Program, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160 and the
Department of Molecular Biology, Princeton University, Lewis Thomas Laboratory, Princeton, New Jersey 08544
Menin is a tumor suppressor that is mutated in patients with multiple endocrine neoplasia type I (MEN1), an inherited tumor-prone syndrome. Because there is no obvious conserved structural domain in menin that suggests a biochemical function, little is known as to how menin suppresses tumorigenisis. Although menin interacts with a variety of nuclear proteins including transcription factors, it is unknown whether menin itself can directly bind DNA. Here we show that menin directly binds to double-stranded DNA. It also binds a variety of DNA structures, including Y-structures, branched structures, and 4-way junction structures. The COOH terminus of menin mediates binding to DNA, but MEN1 disease-derived mutations in the COOH terminus abolish the ability of menin to bind DNA. Importantly, these MEN1 disease-related menin mutants also fail to repress cell proliferation as well as cell cycle progression at the G2/M phase. Furthermore, detailed mutagenesis studies indicate that positively charged residues in two nuclear localization signals mediate direct DNA binding as well as repression of cell proliferation. Collectively, these results demonstrate, for the first time, a novel biochemical activity of menin, binding to DNA, and link its DNA binding to the regulation of cell proliferation.
Received for publication, August 16, 2004
* This work was supported by National Institutes of Health Grant R01 CA113962 (to X. H.), Research Grant RSG-03-055-01-LIB from American Cancer Society (to X. H.), and a scholar award from the Rita Alan Foundation (to X. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 215-746-5565; Fax: 215-746-5525; E-mail: huax{at}mail.med.upenn.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. E. Erfurth, R. Popovic, J. Grembecka, T. Cierpicki, C. Theisler, Z.-B. Xia, T. Stuart, M. O. Diaz, J. H. Bushweller, and N. J. Zeleznik-Le MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression PNAS, May 27, 2008; 105(21): 7517 - 7522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Torkamani and N. J. Schork Accurate prediction of deleterious protein kinase polymorphisms Bioinformatics, November 1, 2007; 23(21): 2918 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. La, Y. Yang, S. K. Karnik, A. C. Silva, R. W. Schnepp, S. K. Kim, and X. Hua Menin-mediated Caspase 8 Expression in Suppressing Multiple Endocrine Neoplasia Type 1 J. Biol. Chem., October 26, 2007; 282(43): 31332 - 31340. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Caslini, Z. Yang, M. El-Osta, T. A. Milne, R. K. Slany, and J. L. Hess Interaction of MLL Amino Terminal Sequences with Menin Is Required for Transformation Cancer Res., August 1, 2007; 67(15): 7275 - 7283. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karhu and L. A. Aaltonen Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update Hum. Mol. Genet., April 15, 2007; 16(R1): R73 - R79. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-X. Chen, J. Yan, K. Keeshan, A. T. Tubbs, H. Wang, A. Silva, E. J. Brown, J. L. Hess, W. S. Pear, and X. Hua The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression PNAS, January 24, 2006; 103(4): 1018 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Karnik, C. M. Hughes, X. Gu, O. Rozenblatt-Rosen, G. W. McLean, Y. Xiong, M. Meyerson, and S. K. Kim Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c PNAS, October 11, 2005; 102(41): 14659 - 14664. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Snabboon, W. Plengpanich, S. Siriwong, N. Wisedopas, S. Suwanwalaikorn, W. Khovidhunkit, and V. Shotelersuk A Novel Germline Mutation, 1793delG, of the MEN1 Gene Underlying Multiple Endocrine Neoplasia Type 1 Jpn. J. Clin. Oncol., May 1, 2005; 35(5): 280 - 282. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |